|
Real-time Estimate
Cboe BZX
19:44:09 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 19.18 USD | -1.41% |
|
-10.42% | +24.24% |
| 09-04 | Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says | MT |
| 08-10 | Wedbush Adjusts Price Target on Jade Biosciences to $47 From $45, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.41% | -10.42% | -11.78% | +25.95% | +24.24% | +151.57% | - | - | - | 1.24B | |
| -3.24% | -7.78% | -7.18% | +8.62% | +0.04% | -5.35% | +10.43% | -30.27% | +194.79% | 48.01B | |
| +0.95% | -0.02% | +1.07% | +39.87% | +162.62% | +410.94% | +536.39% | +584.71% | - | 44.44B | |
| -1.04% | -2.92% | +5.84% | +37.52% | +13.63% | +35.06% | +18.95% | -1.97% | +232.33% | 42.67B | |
| -0.41% | -3.34% | -2.59% | +30.40% | +15.10% | -0.41% | +67.12% | +3.66% | +1,054.85% | 39.96B | |
| 0.00% | -2.61% | -8.13% | +14.87% | +6.22% | +13.09% | +42.33% | -18.57% | +139.05% | 32.75B | |
| -2.68% | -1.89% | +2.59% | +22.99% | - | - | - | - | - | 17.74B | |
| -1.49% | -1.88% | -3.41% | +24.66% | +3.61% | +19.83% | +108.30% | +201.21% | +1,869.20% | 16.49B | |
| -0.37% | -2.53% | +1.28% | +9.17% | +13.69% | +10.91% | +30.93% | -42.85% | +88.27% | 14.38B | |
| -1.40% | -4.86% | +0.21% | +46.21% | +39.15% | +76.38% | +39.03% | -37.34% | +252.44% | 13.4B | |
| +0.64% | +0.14% | -3.60% | +5.43% | -12.16% | -5.25% | -37.34% | -38.19% | +113.03% | 12.22B | |
| -4.09% | +0.48% | +13.04% | +27.49% | +5.40% | -23.17% | - | - | - | 11.6B | |
| -0.05% | -0.03% | +0.21% | +32.83% | +22.90% | +33.35% | +0.90% | -43.11% | +172.43% | 11.34B | |
| -2.50% | -2.14% | -7.93% | +88.56% | +46.64% | +27.88% | +54.18% | -50.20% | - | 10.74B | |
| +0.20% | +4.71% | -8.91% | +17.95% | -15.95% | +32.46% | +505.26% | +182.29% | +2,449.12% | 10.24B | |
| -1.34% | -2.70% | -5.21% | +38.95% | +18.02% | +768.95% | +1,711.67% | +14.91% | - | 9.84B | |
| -0.85% | -2.80% | +6.19% | +49.92% | +48.19% | +165.19% | +504.32% | +79.69% | - | 9.68B | |
| -0.56% | -8.12% | -1.04% | -24.44% | -28.77% | -12.50% | +36.47% | +55.41% | +94.24% | 9.42B | |
| -0.48% | -0.83% | -3.42% | +36.84% | +65.87% | +148.24% | +668.13% | +216.17% | +1,068.31% | 9.44B | |
| +0.19% | -3.82% | -3.06% | +12.61% | -10.20% | -14.15% | -10.28% | -31.40% | +40.62% | 8.76B | |
| Average | -0.94% | -1.08% | -1.79% | +27.32% | +22.01% | +96.48% | +252.16% | +61.42% | +597.59% | 18.72B | |
| Weighted average by Cap. | -0.92% | -1.05% | -1.46% | +26.91% | +30.41% | +91.44% | +190.72% | +86.58% | +524.74% |
- Stock Market
- Stocks
- JBIO Stock
- Sector Jade Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
